跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 494 条关于
“cholangitis”
全部
494
临床试验
340
药物
4
机构
0
资讯
150
去年
Gilead's Seladelpar Receives European Commission Approval for Primary Biliary Cholangitis
去年
New PPAR Agonists Expand Treatment Landscape for Primary Biliary Cholangitis
去年
UK Approves Gilead's Livdelzi (Seladelpar) for Primary Biliary Cholangitis
2年前
Ipsen's Iqirvo Receives U.S. FDA Accelerated Approval for Primary Biliary Cholangitis Treatment
去年
Ipsen's Elafibranor Shows Promise in Phase II Trial for Primary Sclerosing Cholangitis
3个月前
Zydus Therapeutics Receives FDA Priority Review for Saroglitazar in Primary Biliary Cholangitis
去年
COUR Pharmaceuticals' CNP-104 Receives FDA Orphan Drug Designation for Primary Biliary Cholangitis
去年
GSK's Linerixibat Shows Significant Improvement in Cholestatic Pruritus for Primary Biliary Cholangitis Patients
去年
Seladelpar Shows Promise in Stabilizing Liver Stiffness in Primary Biliary Cholangitis Patients
8个月前
Monoclonal Antibody Nebokitug Shows Promise for Rare Liver Disease Primary Sclerosing Cholangitis
第 1 页,共 15 页
上一页
下一页